+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 150 Pages
  • Global
From
From
From
Pancreatic Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pancreatic Cancer - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 142 Pages
  • Global
From
From
Rare NRG1 Fusion - Epidemiology Forecast - 2032 - Product Thumbnail Image

Rare NRG1 Fusion - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 75 Pages
  • Global
From
From
From
From
Low-Grade Glioma - Epidemiology Forecast-2032 - Product Thumbnail Image

Low-Grade Glioma - Epidemiology Forecast-2032

  • Report
  • August 2022
  • 80 Pages
  • Global
From
From
From
From
Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022 - Product Thumbnail Image

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 150 Pages
  • Global
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more